Markets

Lucira Health Slide Continues

January 04, 2023 — 10:19 am EST

Written by RTTNews.com for RTTNews

(RTTNews) - Lucira Health, Inc. (LHDX) shares are sliding more than 21 percent on Wednesday morning trade after reaching a year-to-date high on Tuesday on announcing an Emergency Use Authorization application to the FDA for OTC use of its at-home molecular COVID-19 and Flu test. Today, the medical technology company launched Lucira Connect, a free test to treat telehealth service for COVID-19 or Flu in Canada. Users will get PCR-quality, 99 percent accurate results in less than 30 minutes via their smartphone.

The company said for C$98 people could receive a free telehealth appointment included with the purchase of a test. Lucira Connect is currently offered in British Columbia, Ontario and Alberta with plans to expand.

Currently, shares are at $0.47, down 21.23 percent on a volume of 11,620,342.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned

Latest Articles
Data is currently not available